MEDOCHEMIE was established in 1976 in Cyprus by Dr. Andreas Pittas.
The journey has seen our active expansion into promising markets across the world – from our base in Europe, to the Middle East & Africa, through to the Far East and the Americas. Outside our 21 core offices, we developed a network of trusted agents and partners allowing us to operate in 107 countries.
Our thirteen state-of-the-art manufacturing facilities are designed following the latest technology and fully comply with the current regulations for Good Manufacturing Practices (cGMPs) of the European Union and the World Health Organization (WHO). T
They are located in Cyprus, The Netherlands and Vietnam and can produce oral, parenteral and topical presentations, including penicillins, cephalosporins and dry powder inhalers.
We have acquired and maintain 4,355 marketing authorisation licences for 630 different pharmaceutical products, classified in over 10 therapeutic categories.
We operate in accordance with the strictest quality standards and in full compliance with European guidelines.
The driving force behind MEDOCHEMIE is our 1,880 multinational, talented, quality-focused employees, who work in our manufacturing plants and offices worldwide.
MEDOCHEMIE is a founding member of the Medicines for Europe (former EGA).